Solid Biosciences (SLDB) Current Leases (2018 - 2024)
Historic Current Leases for Solid Biosciences (SLDB) over the last 7 years, with Q3 2024 value amounting to $1.7 million.
- Solid Biosciences' Current Leases fell 698.43% to $1.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.7 million, marking a year-over-year decrease of 698.43%. This contributed to the annual value of $1.9 million for FY2023, which is 221.4% down from last year.
- According to the latest figures from Q3 2024, Solid Biosciences' Current Leases is $1.7 million, which was down 698.43% from $1.7 million recorded in Q2 2024.
- Solid Biosciences' Current Leases' 5-year high stood at $2.0 million during Q4 2020, with a 5-year trough of $412000.0 in Q2 2022.
- In the last 5 years, Solid Biosciences' Current Leases had a median value of $1.8 million in 2020 and averaged $1.6 million.
- As far as peak fluctuations go, Solid Biosciences' Current Leases plummeted by 7251.5% in 2022, and later skyrocketed by 34975.73% in 2023.
- Over the past 5 years, Solid Biosciences' Current Leases (Quarter) stood at $2.0 million in 2020, then plummeted by 36.82% to $1.3 million in 2021, then soared by 50.2% to $1.9 million in 2022, then decreased by 2.21% to $1.9 million in 2023, then decreased by 7.39% to $1.7 million in 2024.
- Its Current Leases was $1.7 million in Q3 2024, compared to $1.7 million in Q2 2024 and $1.7 million in Q1 2024.